Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2026-03-02 @ 11:08 PM
Study NCT ID:
NCT00531206
Status:
COMPLETED
Last Update Posted:
2014-04-07
First Post:
2007-09-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1182.112
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Boehringer Ingelheim, Study Chair
Old Organization:
Boehringer Ingelheim